Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexendar R Perez

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
British Journal of Anaesthesia|February 1, 2020
Anaesthesiologists as translational scientistsJim G Castellanos, Alexendar R Perez, Richard K Perez
Nature Communications|November 10, 2021
CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screensAlexendar R Perez, Laura Sala, Richard K Perez, et al.
Nature Communications|April 2, 2022
Author Correction: CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screensAlexendar R Perez, Laura Sala, Richard K Perez, et al.
British Journal of Anaesthesia|January 24, 2025
CRISPR: fundamental principles and implications for anaesthesiaAlexendar R Perez, Orestes Mavrothalassitis, Janice S Chen, et al.
Nature Biotechnology|March 7, 2017
GuideScan software for improved single and paired CRISPR guide RNA designAlexendar R Perez, Yuri Pritykin, Joana A Vidigal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2016
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial CarcinomaLusha W Liang, Alexendar R Perez, Nicholas A Cangemi, et al.
Cell Reports|November 2, 2023
Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysisI-Li Tan, Alexendar R Perez, Rachel J Lew, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skippingSiddhardha S Maligireddy, Mariana D Mandler, Judith C Lunger, et al.
The New England Journal of Medicine|May 30, 2014
Ibrutinib resistance in chronic lymphocytic leukemiaRichard R Furman, Shuhua Cheng, Pin Lu, et al.
Immunity|December 16, 2018
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during ColitisJim G Castellanos, Viola Woo, Monica Viladomiu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Journal of Anaesthesia|February 1, 2020
Anaesthesiologists as translational scientistsJim G Castellanos, Alexendar R Perez, Richard K Perez
Nature Communications|November 10, 2021
CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screensAlexendar R Perez, Laura Sala, Richard K Perez, et al.
Nature Communications|April 2, 2022
Author Correction: CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screensAlexendar R Perez, Laura Sala, Richard K Perez, et al.
British Journal of Anaesthesia|January 24, 2025
CRISPR: fundamental principles and implications for anaesthesiaAlexendar R Perez, Orestes Mavrothalassitis, Janice S Chen, et al.
Nature Biotechnology|March 7, 2017
GuideScan software for improved single and paired CRISPR guide RNA designAlexendar R Perez, Yuri Pritykin, Joana A Vidigal, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2016
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial CarcinomaLusha W Liang, Alexendar R Perez, Nicholas A Cangemi, et al.
Cell Reports|November 2, 2023
Targeting the non-coding genome and temozolomide signature enables CRISPR-mediated glioma oncolysisI-Li Tan, Alexendar R Perez, Rachel J Lew, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skippingSiddhardha S Maligireddy, Mariana D Mandler, Judith C Lunger, et al.
The New England Journal of Medicine|May 30, 2014
Ibrutinib resistance in chronic lymphocytic leukemiaRichard R Furman, Shuhua Cheng, Pin Lu, et al.
Immunity|December 16, 2018
Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during ColitisJim G Castellanos, Viola Woo, Monica Viladomiu, et al.
Pageof 2